Reynes J - Search Results

1

The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.

Lin YL, Mettling C, Portalès P, Réant B, Robert-Hebmann V, Reynes J, Clot J, Corbeau P. Lin YL, et al. Among authors: reynes j. AIDS. 2006 Jun 26;20(10):1369-77. doi: 10.1097/01.aids.0000233570.51899.e2. AIDS. 2006. PMID: 16791011

2

Interferon-alpha restores HIV-induced alteration of natural killer cell perforin expression in vivo.

Portales P, Reynes J, Pinet V, Rouzier-Panis R, Baillat V, Clot J, Corbeau P. Portales P, et al. Among authors: reynes j. AIDS. 2003 Mar 7;17(4):495-504. doi: 10.1097/00002030-200303070-00004. AIDS. 2003. PMID: 12598769

3

Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection.

Portales P, Reynes J, Rouzier-Panis R, Baillat V, Clot J, Corbeau P. Portales P, et al. Among authors: reynes j. AIDS. 2003 Mar 7;17(4):505-11. doi: 10.1097/00002030-200303070-00005. AIDS. 2003. PMID: 12598770

4

T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonists.

Vincent T, Portales P, Baillat V, de Boever CM, Le Moing V, Vidal M, Ducos J, Clot J, Reynes J, Corbeau P. Vincent T, et al. Among authors: reynes j. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):305-9. J Acquir Immune Defic Syndr. 2005. PMID: 15735449

5

CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.

Lin YL, Portales P, Segondy M, Baillat V, de Boever CM, Le Moing V, Réant B, Montes B, Clot J, Reynes J, Corbeau P. Lin YL, et al. Among authors: reynes j. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):530-6. J Acquir Immune Defic Syndr. 2005. PMID: 16044003

6

The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.

Lin YL, Mettling C, Portalès P, Rouzier R, Clot J, Reynes J, Corbeau P. Lin YL, et al. Among authors: reynes j. AIDS. 2008 Jan 30;22(3):430-2. doi: 10.1097/QAD.0b013e3282f46a6f. AIDS. 2008. PMID: 18195571

7

CCR5 antagonism in HIV infection: ways, effects, and side effects.

Corbeau P, Reynes J. Corbeau P, et al. Among authors: reynes j. AIDS. 2009 Sep 24;23(15):1931-43. doi: 10.1097/QAD.0b013e32832e71cd. AIDS. 2009. PMID: 19724192 Review. No abstract available.

8

High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.

Fiser AL, Vincent T, Brieu N, Lin YL, Portalès P, Mettling C, Reynes J, Corbeau P. Fiser AL, et al. Among authors: reynes j. J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):529-35. doi: 10.1097/QAI.0b013e3181f25bab. J Acquir Immune Defic Syndr. 2010. PMID: 20861743

9

Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.

Lin YL, Mettling C, Portales P, Reynes J, Clot J, Corbeau P. Lin YL, et al. Among authors: reynes j. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15590-5. doi: 10.1073/pnas.242134499. Epub 2002 Nov 14. Proc Natl Acad Sci U S A. 2002. PMID: 12434015 Free PMC article.

10

Low CD4+ T-cell surface CCR5 density as a cause of resistance to in vivo HIV-1 infection.

Reynes J, Baillat V, Portales P, Clot J, Corbeau P. Reynes J, et al. J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):114-6. doi: 10.1097/00126334-200309010-00018. J Acquir Immune Defic Syndr. 2003. PMID: 14501804 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

648 results

Search Page

Filters